131 related articles for article (PubMed ID: 38099729)
1. Quabodepistat (OPC-167832), a Novel Antituberculosis Drug Candidate: Enhancing Oral Bioavailability via Cocrystallization and Mechanistic Analysis of Bioavailability in Two Cocrystals.
Sakamoto N; Miyata K; Fukami T
Mol Pharm; 2024 Jan; 21(1):358-369. PubMed ID: 38099729
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs.
Meng Y; Tan F; Yao J; Cui Y; Feng Y; Li Z; Wang Y; Yang Y; Gong W; Yang M; Kong X; Gao C
Int J Pharm X; 2022 Dec; 4():100119. PubMed ID: 35663355
[TBL] [Abstract][Full Text] [Related]
3. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
Machado TC; Kuminek G; Cardoso SG; Rodríguez-Hornedo N
Eur J Pharm Sci; 2020 Sep; 152():105422. PubMed ID: 32531350
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
Xue N; He B; Jia Y; Yang C; Wang J; Li M
Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
[TBL] [Abstract][Full Text] [Related]
5. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a 1:1 co-crystal of quabodepistat (OPC-167832) with 2,5-di-hydroxy-benzoic acid using microcrystal electron diffraction.
Sakamoto N; Gato K
Acta Crystallogr E Crystallogr Commun; 2023 Oct; 79(Pt 10):920-922. PubMed ID: 37817959
[TBL] [Abstract][Full Text] [Related]
7. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
Ober CA; Gupta RB
AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
[TBL] [Abstract][Full Text] [Related]
8. Improving the dissolution behaviors and bioavailability of abiraterone acetate via multicomponent crystal forms.
Yang Z; Yang Y; Xia M; Dai W; Zhu B; Mei X
Int J Pharm; 2022 Feb; 614():121460. PubMed ID: 35026315
[TBL] [Abstract][Full Text] [Related]
9. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
Kumar S; Gupta A; Mishra CK; Singh S
Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
[TBL] [Abstract][Full Text] [Related]
10. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
11. Explaining dissolution properties of rivaroxaban cocrystals.
Hriňová E; Skořepová E; Čerňa I; Královičová J; Kozlík P; Křížek T; Roušarová J; Ryšánek P; Šíma M; Slanař O; Šoóš M
Int J Pharm; 2022 Jun; 622():121854. PubMed ID: 35623488
[TBL] [Abstract][Full Text] [Related]
12. A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal.
Li W; Pi J; Zhang Y; Ma X; Zhang B; Wang S; Qi D; Li N; Guo P; Liu Z
Fitoterapia; 2018 Sep; 129():85-93. PubMed ID: 29936192
[TBL] [Abstract][Full Text] [Related]
13. Cocrystallization of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicines.
Guo H; Liu S
Chem Pharm Bull (Tokyo); 2023; 71(5):326-333. PubMed ID: 37121683
[TBL] [Abstract][Full Text] [Related]
14. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
15. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds.
Shiraki K; Takata N; Takano R; Hayashi Y; Terada K
Pharm Res; 2008 Nov; 25(11):2581-92. PubMed ID: 18651208
[TBL] [Abstract][Full Text] [Related]
16. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
[TBL] [Abstract][Full Text] [Related]
17. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
[TBL] [Abstract][Full Text] [Related]
18. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
Huang Y; Zhang B; Gao Y; Zhang J; Shi L
J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
[TBL] [Abstract][Full Text] [Related]
19. Rucaparib cocrystal: Improved solubility and bioavailability over camsylate.
Xia M; Jiang Y; Cheng Y; Dai W; Rong X; Zhu B; Mei X
Int J Pharm; 2023 Jan; 631():122461. PubMed ID: 36462737
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in improving oral drug bioavailability by cocrystals.
Emami S; Siahi-Shadbad M; Adibkia K; Barzegar-Jalali M
Bioimpacts; 2018; 8(4):305-320. PubMed ID: 30397585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
